Tarsons Products Q1 Results: Earnings call audio uploaded

1 min read     Updated on 11 Aug 2026, 10:21 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Tarsons Products Limited uploaded the audio of its Q1FY27 earnings call held on August 11, 2026, to its website. The call covered unaudited consolidated and standalone results for the quarter ended June 30, 2026. The disclosure was made pursuant to SEBI LODR regulations, with a transcript to follow.

powered bylight_fuzz_icon
48012678

*this image is generated using AI for illustrative purposes only.

Tarsons Products Limited has uploaded the audio recording of its Investor Conference Call to its official website, providing stakeholders with direct access to management’s discussion on the company’s financial performance. The call took place on Tuesday, August 11, 2026, and focused on the unaudited financial results (consolidated and standalone) for the quarter ended June 30, 2026. This disclosure ensures transparency and allows investors to review the detailed commentary surrounding the latest quarterly figures.

The move is in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Santosh Kumar Agarwal, CFO, Company Secretary & Compliance Officer at Tarsons Products Limited, signed the intimation submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE). The filing confirms that the audio file is now live and accessible via the company’s digital channels.

Investors can access the recording directly through the link provided in the exchange filing: https://www.tarsons.com/wp-content/uploads/2026/08/Tarsons-Products-Q1-FY27-Earnings-Call-Audio.mp3 . The company also stated that a written transcript of the conference call will be shared with the stock exchanges in due course and subsequently uploaded to www.tarsons.com .

Key Details

Detail Information
Event Investor Conference Call
Date Held August 11, 2026
Period Discussed Quarter ended June 30, 2026
Results Type Unaudited Financial Results (Consolidated & Standalone)
Regulatory Basis SEBI LODR Regulation 30, Schedule III
Signatory Santosh Kumar Agarwal (CFO, CS & Compliance Officer)

What This Means for Investors

While the audio upload itself is a procedural compliance step, it serves as the primary channel for investors to gauge management’s tone and strategic priorities for Q1FY27. The availability of the recording allows for immediate analysis of operational updates, margin commentary, and forward-looking guidance before the formal transcript is published. Investors are advised to monitor the company’s website for the upcoming transcript release, which will provide a searchable text record of the discussions.

Historical Stock Returns for Tarsons Products

1 Day5 Days1 Month6 Months1 Year5 Years
-5.20%-6.36%-2.01%+36.07%-20.48%-63.69%

What specific margin pressures or growth drivers did management highlight for Q1 FY27, and how do they compare to previous quarters?

How is Tarsons Products adjusting its pricing strategy in response to current raw material cost fluctuations mentioned in the call?

What are the company's revised full-year revenue and EBITDA guidance implications based on the Q1 performance discussed?

Tarsons Products Q1 Results: Consolidated net loss widens to ₹14.44 million

3 min read     Updated on 11 Aug 2026, 10:05 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Tarsons Products posted a consolidated net loss of ₹14.44 million in Q1FY26, down from a ₹17.83 million profit YoY, due to higher depreciation and finance costs. Standalone profit was ₹6.80 million. The company disclosed ₹41.39 million in excess managerial remuneration requiring shareholder waiver and scheduled its AGM for September 24, 2026.

powered bylight_fuzz_icon
47968523

*this image is generated using AI for illustrative purposes only.

Tarsons Products reported a consolidated net loss of ₹14.44 million for the quarter ended June 30, 2026 (Q1FY26), compared to a net profit of ₹17.83 million in Q1FY25. The decline was primarily driven by increased depreciation and amortization expenses and higher finance costs, which outweighed revenue growth. Despite the consolidated loss, the standalone entity recorded a net profit of ₹6.80 million, up from ₹35.70 million in the corresponding quarter of the previous year. The divergence between standalone and consolidated results highlights the financial performance of its overseas subsidiaries.

The Board of Directors approved the unaudited financial results on August 10, 2026. Price Waterhouse Chartered Accountants LLP served as the statutory auditor, issuing a limited review report under Standard on Review Engagements (SRE) 2410. The filing also disclosed that two subsidiaries, Nerbe plus GmbH & Co. KG and Nerbe R&D GmbH, were not reviewed by their auditors but were deemed immaterial to the Group, contributing a total income of ₹15.66 million and a net loss of ₹17.71 million.

Financial Performance

Consolidated revenue from operations rose to ₹1,102.42 million in Q1FY26, up from ₹913.84 million in Q1FY25. Total income reached ₹1,162.21 million, supported by other income of ₹59.79 million. However, total expenses surged to ₹1,175.45 million from ₹916.68 million year-on-year. Depreciation and amortization expenses jumped to ₹270.20 million from ₹199.36 million, while finance costs increased to ₹62.65 million from ₹50.71 million. Employee benefits expense also rose to ₹212.13 million from ₹178.62 million.

Metric Q1FY26 (₹ Million) Q1FY25 (₹ Million) Change
Revenue from Operations 1,102.42 913.84 +20.6%
Total Income 1,162.21 947.00 +22.7%
Total Expenses 1,175.45 916.68 +28.2%
Profit Before Tax (13.24) 30.32 Turnaround
Net Profit/Loss (14.44) 17.83 Turnaround

Standalone revenue grew to ₹861.47 million from ₹712.79 million in Q1FY25. Standalone total income was ₹929.01 million against expenses of ₹919.79 million, resulting in a profit before tax of ₹9.22 million. After a tax expense of ₹2.42 million, the standalone net profit stood at ₹6.80 million, compared to ₹35.70 million in Q1FY25.

Segment-wise Breakdown

The Group operates in two primary geographical segments: India and Germany. India contributed ₹861.14 million to segment revenue in Q1FY26, up from ₹712.68 million in Q1FY25. Germany’s revenue increased to ₹241.28 million from ₹200.96 million. Segment results before exceptional items, interest, tax, and depreciation (EBITDA) for India were ₹294.35 million, while Germany reported ₹24.14 million.

Segment Revenue Q1FY26 (₹ Million) Revenue Q1FY25 (₹ Million) EBITDA Q1FY26 (₹ Million)
India 861.14 712.68 294.35
Germany 241.28 200.96 24.14
Rest of World - - (1.88)
Total 1,102.42 913.64 316.61

Governance and Disclosures

Tarsons disclosed that during FY26, it paid excess managerial remuneration totaling ₹41.39 million, comprising ₹19.67 million to the Managing Director, ₹20.51 million to the Whole Time Director, and ₹1.21 million to other directors. This exceeds the limits under Section 197 of the Companies Act, 2013. The company seeks shareholder approval for a waiver via a special resolution at its upcoming Annual General Meeting.

Additionally, the Board fixed September 24, 2026, as the date for the 43rd Annual General Meeting (AGM), to be held via video conferencing. The cut-off date for e-voting is set for September 17, 2026. The filing also noted the statutory impact of new labour codes implemented in November 2025, which resulted in an exceptional item charge of ₹11.27 million in FY26 due to past service cost recognition under Ind AS 19.

What the Numbers Show

The widening gap between standalone profitability and consolidated losses underscores the pressure on Tarsons’ overseas operations. While the Indian segment delivered strong EBITDA growth, the German subsidiary’s contribution margin appears thin relative to its revenue base. The significant jump in depreciation costs—likely linked to recent capital expenditures or asset revaluations—has heavily impacted the bottom line, turning a previously profitable quarter into a loss-making one on a consolidated basis. Investors should monitor the outcome of the special resolution regarding excess remuneration, as it reflects ongoing governance adjustments within the management structure.

Historical Stock Returns for Tarsons Products

1 Day5 Days1 Month6 Months1 Year5 Years
-5.20%-6.36%-2.01%+36.07%-20.48%-63.69%

How will the significant increase in depreciation and amortization expenses impact Tarsons' cash flow projections for the remainder of FY26?

What strategic measures is management implementing to improve the thin contribution margins of its German subsidiary, Nerbe plus?

Could the pending shareholder approval for excess managerial remuneration affect investor confidence or lead to governance-related stock volatility?

More News on Tarsons Products

1 Year Returns:-20.48%